Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review.

@article{Colosia2014ClinicalEA,
  title={Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review.},
  author={Ann D Colosia and Annete Njue and Peter C. Trask and Robert Olivares and Shahnaz Khan and Adeline Abbe and Rachel L Police and Jianmin Wang and Rodrigo Ruiz-Soto and James A. Kaye and Farrukh T Awan},
  journal={Clinical lymphoma, myeloma & leukemia},
  year={2014},
  volume={14 5},
  pages={343-355.e6}
}
This systematic literature review was designed to assess information on the clinical efficacy and safety of interventions used in the treatment of refractory or relapsed diffuse large B-cell lymphoma (R/R DLBCL) and to perform a meta-analysis if possible. We searched databases (PubMed, EMBASE, and Cochrane Library for articles from 1997 to August 2, 2012 reported in English), conference abstracts, bibliographic reference lists, and the ClinicalTrials.gov database for phase II to IV studies with… CONTINUE READING